期刊文献+

胸段食管癌淋巴结转移规律与术后放疗范围的探讨 被引量:41

Rule of lymph node metastasis and proper target of postoperative radiotherapy for thoracic esophageal carcinoma
原文传递
导出
摘要 目的分析胸段食管癌淋巴结转移规律、失败部位,为术后放疗范围提供依据。方法549例食管癌根治术后患者随机进入单纯手术组(275例)和术后放疗组(274例)。术后放疗组术后3~4周开始双锁骨上淋巴引流区和全纵隔放疗50~60Gy分25~30次5~6周完成。结果全组1、2个解剖区域淋巴结转移者5年生存率分别为31.5%、13.9%(P=0.013),单纯手术组淋巴结转移个数≥2个(82例)的分别为24.8%、4.9%(P=0.046)。上、中、下段食管癌淋巴结切除均数分别为13、17、20个,上、中、下段食管癌淋巴结转移率分别为26.1%、49.6%、64.9%(X^2=15.51,P〈0.01)。胸段食管癌食管旁、纵隔、胃周围(贲门左、贲门右、胃小弯)淋巴结转移率分别为33.2%、12.4%、30.4%(X^2=79.93,P〈0.01),在上、中、下段食管癌中食管旁淋巴结阳性率相似(61.5%、65.6%、64.9%,X^2=0.16,P〉0.05)。在单纯手术组,纵隔淋巴结转移和锁骨上淋巴结转移失败率上、中段分别为26.7%、29.8%和16.7%、14.3%。上二段食管癌吻合口的复发率16.7%明显的高于中、下段(3.1%、7.7%,X^2=9.02,P=0.011)。结论食管癌术后生存率受淋巴结转移区域多少的影响。上段食管癌淋巴结转移率低町能与淋巴结清扫个数少有关,发生在食管旁淋巴结转移率最高,且不受病变部位的影响。上、中段食管癌除纵隔、锁骨上区域的复发率高外,上段食管癌的吻合口也很高,这些部位应是术后放疗的重点。 Objective To analyze the rule of lymph node metastasis in thoracic esophageal carcinoma,and to study the proper radiation target. Methods From September 1986 to December 1997,549 patients with esophageal carcinoma who had undergone radical resection were divided into surgery alone group (S,275 patients) or surgery plus radiotherapy group( S + R,274 patients). Radiotherapy was begun 3 to 4 weeks after operation. The radiation target included both supra-clavicular areas and the entire mediastinum. The total dose was 50 Gy in 25 fractions over 5 weeks for the supra-clavicular areas and 60 Gy in 30 fractions over 6 weeks for the entire mediastinum. Results The 5-year overall survival of patients with lymph node metastasis in one anatomic site and two anatomic sites was 31.5% and 13.9% (P = 0. 013 ) ,respectively. For patients with 〉 2 positive nodes metastasis receiving surgery alone, the corresponding 5-year survival was 24.8% and 4.9% (P =0. 046),respectively. The median number of dissected lymph nodes of the upper-, middle-and lower-segment esophageal carcinoma was 13,17 and 20, respectively. The rate of metastatic lymph node in the para-esophagus region was the highest (61.5% -64.9% ) ,which was not different among the different primary sites (P = 0.922). The anastomotic stoma recurrence rate of the upper-segment esopha- geal carcinoma was higher than that of the middle- or lower-segment carcinomas ( 16.7 %, 3.1% , and 7.7 % , X^2 = 9.02, P 〈 0.05). Conclusions For the thoracic esophageal carcinoma, the number of anatomic sites of lymph node metastasis is an important factor affecting the survival. The lower rate of lymph node metasta- sis of the upper segment esophageal carcinoma may be corrected with the less lymph node dissected. The rate of lymph node metastasis in para-esophageal region is not related with the lesion segment. The anastomotic stoma is an important radiotherapy target for upper segment esophageal carcinoma.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2008年第6期427-431,共5页 Chinese Journal of Radiation Oncology
基金 首都医学发展科研基金(2007-2022)
关键词 食管肿瘤/放射疗法 淋巴结转移规律 术后放疗范围 Esophageal neoplasms/radiotherapy Rule of the lymph node metastasis Field ofpostoperative radiotherapy
  • 相关文献

参考文献25

  • 1Fok M,Sham JS, Choy D,et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery, 1993,113 : 138-147.
  • 2Teniere P, Hay JM, Fingerhut A, et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multhicenter controlled trial. Surg Gynecol Obstet, 1991,173 : 123- 129.
  • 3Zieren HU, Muller JM, Jacobi CA, et al. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus : a prospective randomized study. World J Surgery, 1995,19:444-449.
  • 4梅泽如,项其昌,吴维继,蒋向民,冯存伟,穆怀德.食管癌术后预防性放疗前瞻性研究[J].中华放射肿瘤学杂志,1997,6(3):188-189. 被引量:32
  • 5XiaoZF, Yang ZY, Liang J, et al. Value of radiotherapy after radical surgery for esophageal carcionma: a report of 495 patients. Ann Thorac Surg,2003 ,75 :331-336.
  • 6Xiao ZF,Yang ZY, Miao Y J, et al. Influence of number of metastatic lymph node on the survival of curative resected thoracic esophageal cancer and its value of radiotherapy: randomized controlled trial on 549 cases. Int J Radiat Oncol Biol Phys,2005,62: 82-86.
  • 7Skinner DB, Ferguson MD,Soriano A,et al. Selection of operation for esophageal cancer based on staging. Ann Surg, 1986,204:391- 401.
  • 8Ellis FH Jr, Heatley G J, Krasna M J, et al. Esophagogastrectomy for carcinoma of the esophagus and eardia: a comparison of findings and results after standard resection in three consecutive eight-year inter-vals with improved staging criteria. J Thorae Cardiovase Surg, 1997,113:836-848.
  • 9Korst R J, Rusch VW, Venkatraman E, et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg, 1998,115:660-670.
  • 10Tachibana M, Kinugasa S, Dhar DK, et al. Dukes' classification as a useful staging system in resectable squamous cell carcinoma of the esophagus. Virchows Arch,2001,438:350-356.

二级参考文献2

  • 1杨宗贻,中国放射肿瘤学,1991年,3卷,141页
  • 2黄国俊,中华外科杂志,1987年,25卷,449页

共引文献54

同被引文献384

引证文献41

二级引证文献277

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部